Secondary hyperaldosteronism historical perspective: Difference between revisions
Jump to navigation
Jump to search
(Created page with "__NOTOC__ {{Secondary hyperaldosteronism}} {{CMG}}; '''Associate Editor-In-Chief:''' {{MJ}} ==Overview==") |
No edit summary |
||
Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
== Historical Perspective == | |||
* From 1960s to early 1970s, its techniques of diagnosis and treatment were greatly improved by the availability of [[spironolactone]], realization of the [[renin-angiotensin-aldosterone system]], and progress in laboratory tests and adrenal venous sampling. | |||
* On October 19, 1964, Jerome W. Conn, Edwin L. Cohen and David R. Rovner differentiated between primary and secondary aldosteronism in [[Hypertension|hypertensive]] disease.<ref name="pmid3881606">{{cite journal |vauthors=Conn JW, Cohen EL, Rovner DR |title=Landmark article Oct 19, 1964: Suppression of plasma renin activity in primary aldosteronism. Distinguishing primary from secondary aldosteronism in hypertensive disease. By Jerome W. Conn, Edwin L. Cohen and David R. Rovner |journal=JAMA |volume=253 |issue=4 |pages=558–66 |year=1985 |pmid=3881606 |doi= |url= |issn=}}</ref> | |||
* In 1970s, there was an extensive application of modern imaging modalities, such as [[CT scanning]], adrenal venous sampling and [[steroid]] analysis.<ref name="pmid12933492">{{cite journal |vauthors=Lingam RK, Sohaib SA, Vlahos I, Rockall AG, Isidori AM, Monson JP, Grossman A, Reznek RH |title=CT of primary hyperaldosteronism (Conn's syndrome): the value of measuring the adrenal gland |journal=AJR Am J Roentgenol |volume=181 |issue=3 |pages=843–9 |year=2003 |pmid=12933492 |doi=10.2214/ajr.181.3.1810843 |url= |issn=}}</ref> | |||
==References== | |||
{{reflist|2}} | |||
{{WH}} | |||
{{WS}} | |||
[[Category:Endocrinology]] |
Latest revision as of 20:11, 14 September 2017
Secondary hyperaldosteronism Microchapters |
Differentiating Secondary Hyperaldosteronism from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Secondary hyperaldosteronism historical perspective On the Web |
American Roentgen Ray Society Images of Secondary hyperaldosteronism historical perspective |
Secondary hyperaldosteronism historical perspective in the news |
Blogs on Secondary hyperaldosteronism historical perspective |
Risk calculators and risk factors for Secondary hyperaldosteronism historical perspective |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor-In-Chief: Mehrian Jafarizade, M.D [2]
Overview
Historical Perspective
- From 1960s to early 1970s, its techniques of diagnosis and treatment were greatly improved by the availability of spironolactone, realization of the renin-angiotensin-aldosterone system, and progress in laboratory tests and adrenal venous sampling.
- On October 19, 1964, Jerome W. Conn, Edwin L. Cohen and David R. Rovner differentiated between primary and secondary aldosteronism in hypertensive disease.[1]
- In 1970s, there was an extensive application of modern imaging modalities, such as CT scanning, adrenal venous sampling and steroid analysis.[2]
References
- ↑ Conn JW, Cohen EL, Rovner DR (1985). "Landmark article Oct 19, 1964: Suppression of plasma renin activity in primary aldosteronism. Distinguishing primary from secondary aldosteronism in hypertensive disease. By Jerome W. Conn, Edwin L. Cohen and David R. Rovner". JAMA. 253 (4): 558–66. PMID 3881606.
- ↑ Lingam RK, Sohaib SA, Vlahos I, Rockall AG, Isidori AM, Monson JP, Grossman A, Reznek RH (2003). "CT of primary hyperaldosteronism (Conn's syndrome): the value of measuring the adrenal gland". AJR Am J Roentgenol. 181 (3): 843–9. doi:10.2214/ajr.181.3.1810843. PMID 12933492.